19th Sep 2007 16:37
Skyepharma PLC19 September 2007 SKYEPHARMA TO PRESENT AT UBS 2007 GLOBAL LIFE SCIENCES CONFERENCE LONDON, UK, 19 September 2007-- SkyePharma PLC (LSE: SKP) announces today thatthe Company's Chief Executive Officer, Frank Condella, will make a presentationat the UBS 2007 Global Life Sciences Conference in New York. Mr Condella willdeliver his presentation on Thursday 27 September 2007 at 12.30 p.m. EDT (5.30p.m. UKT). Investors may access an audio webcast of the presentation atwww.skyepharma.com under the Investor Relations tab. For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has eleven approved products in the areas of oral,inhalation and topical delivery that are marketed throughout the world byleading pharmaceutical companies. For more information, visit www.skyepharma.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L